The IPOX^® Update archive

Jan2025

25 January 2025

The IPOX^® Update 1/25/2025

US IPO market shows signs of heating up in early 2025 with notable confidential filings like Voyager Technologies in space and defense ($2-3B valuation). Odyssey Therapeutics (biotech), SailPoint (cybersecurity), and Metsera (obesity drugs) have also filed for IPOs on Nasdaq. While January saw a slow start, NYSE anticipates a robust IPO market recovery driven by a strong economy and potentially lower interest rates, suggesting a positive outlook for US listings in the coming months.

Read edition →

Jan2025

18 January 2025

The IPOX^® Update 1/18/2025

U.S. IPO activity is picking up with eToro's potential $5 billion+ and Klarna's possible $20 billion IPO. Titan America aims to raise over $500 million. In Asia, LG CNS priced its IPO at $823 million, and Guming Holdings targets $300 million in Hong Kong. Europe sees HBX Group's €725 million IPO. Riyad Capital's potential $2.5 billion IPO leads activity in MENA.

Read edition →

Jan2025

11 January 2025

The IPOX^® Update 1/11/2025

IPO activity is picking up globally, with the US seeing filings from biotech firms like Maze and Metsera. Europe anticipates large listings from Stada and HBX Group, while Shein and Shawbrook consider London. In Asia, NTT plans a Singapore REIT IPO, and several Chinese firms eye Hong Kong, though CATL's faces US blacklisting concerns. LG CNS launched its IPO in South Korea, while K Bank canceled its attempt. Saudi Tabreed is planning a potential Riyadh IPO.

Read edition →

Jan2025

4 January 2025

The IPOX^® Update 1/4/2025

EG Group, a UK-based fuel station operator, is planning a U.S. IPO valued at over $16 billion. Ascentage Pharma seeks $100 million in a Nasdaq IPO for cancer treatments. Germany's IPO market anticipates growth in 2025 with major listings. Chery Auto aims for a $1 billion Hong Kong IPO, valuing it at $14 billion. Meanwhile, Hong Kong will see 8 IPOs raising $755 million by mid-January 2025, reflecting robust investor interest.

Read edition →

Dec2024

21 December 2024

The IPOX^® Update 12/21/2024

In recent IPO news, the US market sees Databricks potentially delaying its IPO post-funding, while FedEx explores options for its freight division. Shifting focus internationally, there's positive momentum as EV battery giant CATL considers a significant Hong Kong listing. Adding to the upbeat news, Greek multinational METLEN is advancing its multi-billion pound London IPO, showcasing confidence in European markets.

Read edition →

Dec2024

14 December 2024

The IPOX^® Update 12/14/2024

London's IPO market shows mixed signals with French streaming firm Canal+ planning a €5-6 billion listing, while facing challenges with Shein's delayed approval over supply chain concerns. In Asia, Orion Breweries prepares for a $200 million Tokyo listing, Foshan Haitian seeks a HK$1.5 billion Hong Kong dual listing, and Kioxia completed an $800 million IPO, though at a valuation significantly below its 2018 level.

Read edition →

Dec2024

7 December 2024

The IPOX^® Update 12/07/2024

Recent IPO announcements reflect strong global market activity across diverse sectors. Notable listings include Holcim's $30 billion North American spin-off, Seven & i's $6.6 billion 7-Eleven USA IPO, and ServiceTitan's $5.16 billion tech listing in the U.S. The MENA region sees healthcare and retail offerings from Almoosa Health and Nice One, while Asia-Pacific activity includes Kioxia's $727 million Tokyo listing and Mao Geping's $270 million Hong Kong debut.

Read edition →

Nov2024

30 November 2024

The IPOX^® Update 11/30/2024

Global companies are preparing IPOs amid varied market conditions. In the U.S., ServiceTitan and CoreWeave plan significant offerings despite financial pressures. European firms like Apotea, Thyssenkrupp's Marine Systems, Odido, and Cirsa are set for listings. In Asia-Pacific, Insta360 and Mr DIY's Indonesian arm aim to go public. MENA's Talabat plans the UAE's largest IPO. Biotech firms Odyssey and Aktis proceed despite sector uncertainties, and Australia's Anteris files for a U.S. IPO.

Read edition →

Nov2024

22 November 2024

The IPOX^® Update 11/22/2024

Medline Industries plans a $5B U.S. IPO in 2025, potentially valuing the company at $50B. Pony AI seeks $260M in a U.S. IPO with Uber investing $10M. ServiceTitan files for Nasdaq listing, targeting SaaS growth. Canadian retailer Groupe Dynamite raises $300M. In Asia, Kioxia aims for $4.8B valuation, while Talabat targets $1.5B in Dubai. Australian DigiCo REIT launches a $1.8B IPO. UAE’s Pure Harvest eyes IPO by 2028.

Read edition →